Watch NBIX. Know when insiders buy.
One email the day a filing lands. Free.
NBIX
NEUROCRINE BIOSCIENCES INC
141.31
−0.69 −0.49%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
26
FLAG · insiders 27, shorts 25
Insiders, 90 days
−$826K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $14.4BP/E 20.7DIV YIELD —FCF YIELD 6.06%REV TTM $3.4B +34.4%NET INCOME $705.5M +102.6%NET CASH —52W 123.10 – 185.50SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Renaissance Technologies | Guru | #28 | $393.7M | 2.3M | 2026-06-30 |
| Caisse de dépôt (CDPQ) | Pension | #177 | $91M | 540K | 2026-06-30 |
| Bridgewater Associates (Ray Dalio) | Guru | #117 | $34.7M | 206K | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
JPMORGAN CHASE & CO.5.2%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.